Bosh sahifa688235 ā¢ SHA
add
BeOne Medicines AG
Yopilish kursi
275,20Ā Ā„
Kunlik diapazon
277,64Ā Ā„ - 282,00Ā Ā„
Yillik diapazon
151,13Ā Ā„ - 346,00Ā Ā„
Bozor kapitalizatsiyasi
291,32Ā mlrd CNY
OŹ»rtacha hajm
3,24Ā mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
SHA
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,41Ā mlrd | 41,00% |
Joriy xarajat | 1,05Ā mlrd | 10,64% |
Sof foyda | 124,84Ā mln | 202,88% |
Sof foyda marjasi | 8,84 | 172,94% |
Har bir ulushga tushum | 1,09 | 267,89% |
EBITDA | 198,86Ā mln | 496,46% |
Amaldagi soliq stavkasi | 15,17% | ā |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 4,04Ā mlrd | 48,74% |
Jami aktivlari | 7,63Ā mlrd | 31,04% |
Jami passivlari | 3,50Ā mlrd | 47,29% |
Umumiy kapital | 4,13Ā mlrd | ā |
Tarqatilgan aksiyalar | 110,66Ā mln | ā |
Narxi/balansdagi bahosi | 7,37 | ā |
Aktivlardan daromad | 5,85% | ā |
Kapitaldan daromad | 8,20% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 124,84Ā mln | 202,88% |
Operatsiyalardan naqd pul | 402,55Ā mln | 113,70% |
Sarmoyadan naqd pul | -49,27Ā mln | 63,20% |
Moliyadan naqd pul | 961,27Ā mln | 7Ā 491,79% |
Naqd pulning sof oŹ»zgarishi | 1,32Ā mlrd | 1Ā 286,91% |
BoŹ»sh pul | 306,27Ā mln | 120,68% |
Haqida
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Tashkil etilgan
28-okt, 2010
Xodimlar soni
11Ā 000
